annual SGA:
$14.75B+$1.88B(+14.61%)Summary
- As of today (May 29, 2025), ABBV annual SGA is $14.75 billion, with the most recent change of +$1.88 billion (+14.61%) on December 31, 2024.
- During the last 3 years, ABBV annual SGA has risen by +$2.40 billion (+19.46%).
- ABBV annual SGA is now -3.33% below its all-time high of $15.26 billion, reached on December 31, 2022.
Performance
ABBV SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$3.29B-$562.00M(-14.58%)Summary
- As of today (May 29, 2025), ABBV quarterly SGA is $3.29 billion, with the most recent change of -$562.00 million (-14.58%) on March 1, 2025.
- Over the past year, ABBV quarterly SGA has dropped by -$22.00 million (-0.66%).
- ABBV quarterly SGA is now -39.15% below its all-time high of $5.41 billion, reached on June 30, 2022.
Performance
ABBV quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$26.16B-$7.14B(-37.56%)Summary
- As of today (May 29, 2025), ABBV TTM SGA is -$26.16 billion, with the most recent change of -$7.14 billion (-37.56%) on March 1, 2025.
- Over the past year, ABBV TTM SGA has dropped by -$39.31 billion (-298.96%).
- ABBV TTM SGA is now -213.64% below its all-time high of $23.02 billion.
Performance
ABBV TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ABBV Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.6% | -0.7% | -299.0% |
| 3 y3 years | +19.5% | +5.3% | -307.1% |
| 5 y5 years | +112.5% | +94.3% | -476.0% |
ABBV Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3.3% | +19.5% | -39.1% | +8.4% | -242.5% | at low |
| 5 y | 5-year | -3.3% | +112.5% | -39.1% | +94.3% | -242.5% | at low |
| alltime | all time | -3.3% | +340.6% | -39.1% | +216.3% | -213.6% | at low |
ABBV Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $3.29B(-14.6%) | $14.73B(-0.1%) |
| Dec 2024 | $14.75B(+14.6%) | $3.85B(-8.3%) | $14.75B(+4.7%) |
| Sep 2024 | - | $4.21B(+24.5%) | $14.09B(+6.3%) |
| Jun 2024 | - | $3.38B(+1.9%) | $13.26B(+0.8%) |
| Mar 2024 | - | $3.31B(+3.8%) | $13.15B(+2.1%) |
| Dec 2023 | $12.87B(-15.6%) | $3.19B(-5.3%) | $12.87B(-1.7%) |
| Sep 2023 | - | $3.37B(+3.2%) | $13.10B(+0.5%) |
| Jun 2023 | - | $3.27B(+7.5%) | $13.03B(-14.1%) |
| Mar 2023 | - | $3.04B(-11.1%) | $15.17B(-0.6%) |
| Dec 2022 | $15.26B(+23.6%) | $3.42B(+3.4%) | $15.26B(+1.0%) |
| Sep 2022 | - | $3.30B(-39.0%) | $15.10B(+1.5%) |
| Jun 2022 | - | $5.41B(+73.1%) | $14.88B(+17.8%) |
| Mar 2022 | - | $3.13B(-4.1%) | $12.63B(+2.3%) |
| Dec 2021 | $12.35B(+9.3%) | $3.26B(+5.7%) | $12.35B(+0.2%) |
| Sep 2021 | - | $3.08B(-2.6%) | $12.32B(+2.0%) |
| Jun 2021 | - | $3.16B(+11.3%) | $12.08B(-2.9%) |
| Mar 2021 | - | $2.84B(-12.0%) | $12.45B(+10.2%) |
| Dec 2020 | $11.30B(+62.8%) | $3.23B(+13.5%) | $11.30B(+12.8%) |
| Sep 2020 | - | $2.85B(-19.3%) | $10.02B(+13.5%) |
| Jun 2020 | - | $3.53B(+108.1%) | $8.83B(+26.9%) |
| Mar 2020 | - | $1.70B(-13.1%) | $6.96B(+0.2%) |
| Dec 2019 | $6.94B(-6.2%) | $1.95B(+17.7%) | $6.94B(+0.3%) |
| Sep 2019 | - | $1.66B(+0.2%) | $6.92B(-3.6%) |
| Jun 2019 | - | $1.65B(-1.5%) | $7.18B(-1.5%) |
| Mar 2019 | - | $1.68B(-12.9%) | $7.29B(-1.5%) |
| Dec 2018 | $7.40B(+17.5%) | $1.93B(+0.5%) | $7.40B(-0.4%) |
| Sep 2018 | - | $1.92B(+9.0%) | $7.43B(+6.6%) |
| Jun 2018 | - | $1.76B(-1.7%) | $6.96B(+3.7%) |
| Mar 2018 | - | $1.79B(-8.4%) | $6.71B(+6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $6.29B(+7.0%) | $1.96B(+34.2%) | $6.29B(+4.6%) |
| Sep 2017 | - | $1.46B(-3.4%) | $6.02B(+1.3%) |
| Jun 2017 | - | $1.51B(+9.9%) | $5.94B(+0.7%) |
| Mar 2017 | - | $1.37B(-18.2%) | $5.90B(+0.3%) |
| Dec 2016 | $5.88B(-7.9%) | $1.68B(+21.6%) | $5.88B(-1.0%) |
| Sep 2016 | - | $1.38B(-5.8%) | $5.94B(-1.5%) |
| Jun 2016 | - | $1.47B(+8.2%) | $6.03B(-3.8%) |
| Mar 2016 | - | $1.35B(-22.0%) | $6.27B(-1.8%) |
| Dec 2015 | $6.39B(-17.3%) | $1.74B(+17.8%) | $6.39B(-20.1%) |
| Sep 2015 | - | $1.47B(-13.4%) | $7.99B(-1.5%) |
| Jun 2015 | - | $1.70B(+15.6%) | $8.11B(+3.2%) |
| Mar 2015 | - | $1.47B(-55.9%) | $7.86B(+1.7%) |
| Dec 2014 | $7.72B(+44.3%) | $3.34B(+109.5%) | $7.72B(+32.5%) |
| Sep 2014 | - | $1.59B(+10.2%) | $5.83B(+6.1%) |
| Jun 2014 | - | $1.45B(+8.1%) | $5.50B(+0.8%) |
| Mar 2014 | - | $1.34B(-7.5%) | $5.46B(+1.9%) |
| Dec 2013 | $5.35B(+7.3%) | $1.45B(+14.8%) | $5.35B(+0.7%) |
| Sep 2013 | - | $1.26B(-10.3%) | $5.32B(+3.4%) |
| Jun 2013 | - | $1.41B(+13.7%) | $5.14B(+3.2%) |
| Mar 2013 | - | $1.24B(-12.3%) | $4.98B(-0.2%) |
| Dec 2012 | $4.99B(-15.4%) | $1.41B(+30.0%) | $4.99B(+5.9%) |
| Sep 2012 | - | $1.08B(-12.9%) | $4.71B(-23.6%) |
| Jun 2012 | - | $1.25B(-0.1%) | $6.17B(+3.4%) |
| Mar 2012 | - | $1.25B(+9.9%) | $5.96B(+1.2%) |
| Dec 2011 | $5.89B(+54.3%) | $1.13B(-55.4%) | $5.89B(+23.8%) |
| Sep 2011 | - | $2.54B(+144.1%) | $4.76B(+114.5%) |
| Jun 2011 | - | $1.04B(-11.6%) | $2.22B(+88.4%) |
| Mar 2011 | - | $1.18B | $1.18B |
| Dec 2010 | $3.82B(+14.1%) | - | - |
| Dec 2009 | $3.35B | - | - |
FAQ
- What is AbbVie annual SGA?
- What is the all time high annual SGA for AbbVie?
- What is AbbVie annual SGA year-on-year change?
- What is AbbVie quarterly SGA?
- What is the all time high quarterly SGA for AbbVie?
- What is AbbVie quarterly SGA year-on-year change?
- What is AbbVie TTM SGA?
- What is the all time high TTM SGA for AbbVie?
- What is AbbVie TTM SGA year-on-year change?
What is AbbVie annual SGA?
The current annual SGA of ABBV is $14.75B
What is the all time high annual SGA for AbbVie?
AbbVie all-time high annual SGA is $15.26B
What is AbbVie annual SGA year-on-year change?
Over the past year, ABBV annual SGA has changed by +$1.88B (+14.61%)
What is AbbVie quarterly SGA?
The current quarterly SGA of ABBV is $3.29B
What is the all time high quarterly SGA for AbbVie?
AbbVie all-time high quarterly SGA is $5.41B
What is AbbVie quarterly SGA year-on-year change?
Over the past year, ABBV quarterly SGA has changed by -$22.00M (-0.66%)
What is AbbVie TTM SGA?
The current TTM SGA of ABBV is -$26.16B
What is the all time high TTM SGA for AbbVie?
AbbVie all-time high TTM SGA is $23.02B
What is AbbVie TTM SGA year-on-year change?
Over the past year, ABBV TTM SGA has changed by -$39.31B (-298.96%)